ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CXC Chemokine Receptor 2 Accelerates Tubular Cell Senescence and Renal Fibrosis via β-Catenin-Induced Mitochondrial Dysfunction

Meng, Ping; Huang, Jiewu; Ling, Xian; Zhou, Shan; Wei, Jingyan; Zhu, Mingsheng; Miao, Jinhua; Shen, Weiwei; Li, Jiemei; Ye, Huiyun; Niu, Hongxin*; Zhang, Yunfang*; Zhou, Lili*南方医科大学
Frontiers in Cell and Developmental Biology2022-5-3DOI: 10.3389/fcell.2022.862675
4被引9阅读
引用收藏
分享

摘要

Renal fibrosis is a common feature of various chronic kidney diseases (CKD). However, its underlying mechanism has not been totally clarified. C-X-C motif chemokine receptor (CXCR) family plays a role in renal fibrosis, however, detailed mechanisms have not been elucidated. Here, we report that CXCR2 has a potential role in tubular cell senescence and renal fibrosis, and is associated with beta-catenin-activated mitochondrial dysfunction. CXCR2 is one of most increased members among CXCR family in unilateral ureteral obstruction (UUO) mice. CXCR2 was expressed primarily in tubules and co-localized with p16(INK4A), a cellular senescence marker, and beta-catenin. Administration of SB225002, a selective CXCR2 antagonist, significantly inhibited the activation of beta-catenin signaling, restored mitochondrial function, protected against tubular cell senescence and renal fibrosis in unilateral ureteral obstruction (UUO) mice. In unilateral ischemia-reperfusion injury (UIRI) mice, treatment with interlukin-8 (IL-8), the ligand of CXCR2, further aggravated beta-catenin activation, mitochondrial dysfunction, tubular cell senescence and renal fibrosis, whereas knockdown of p16(INK4A) inhibited IL-8-induced these effects. In vitro, SB225002 inhibited mitochondrial dysfunction and tubular cell senescence. Furthermore, ICG-001, a beta-catenin signaling blocker, significantly retarded CXCR2-induced cellular senescence and fibrotic changes. These results suggest that CXCR2 promotes tubular cell senescence and renal fibrosis through inducing beta-catenin-activated mitochondrial dysfunction.

学科与关键词

关键词
CXCR2beta-cateninrenal fibrosistubular cell senescencemitochondrial dysfunction
相关
加载中…
  • Cannabinoid receptor 2 plays a central role in renal tubular mitochondrial dysfunction and kidney ageing
    Zhou, Shan; Ling, Xian; Meng, Ping; Liang, Ye; Shen, Kunyu; Wu, Qinyu; Zhang, Yunfang; Chen, Qiyan; Chen, Shuangqin; Liu, Youhua; Zhou, Lili*Journal of Cellular and Molecular Medicine, 2021, 25(18): 8957-8972.被引 12
  • Pentraxin 3 plays a key role in tubular cell senescence and renal fibrosis through inducing ?-catenin signaling
    Luo, Pei; Zhang, Haixia; Liang, Ye; Li, Xiaolong; Wen, Zhen; Xia, Chaoying; Lan, Xiaolei; Yang, Yaya; Xiong, Yabing; Huang, Jiewu; Ling, Xian; Zhou, Shan; Miao, Jinhua; Shen, Weiwei; Hou, Fan Fan; Liu, Youhua; Zhou, Lili*; Liang, Min*Biochimica et Biophysica Acta - Molecular Basis of Disease, 2023, 1869(7): 166807.
  • Brahma-related gene-1 promotes tubular senescence and renal fibrosis through Wnt/β-catenin/autophagy axis
    Gong, Wangqiu; Luo, Congwei; Peng, Fenfen; Xiao, Jing; Zeng, Yiqun; Yin, Bohui; Chen, Xiaowen; Li, Shuting; He, Xiaoyang; Liu, Yanxia; Cao, Huihui*; Xu, Jiangping*; Long, Haibo*Clinical Science, 2021, 135(15): 1873-1895.被引 24
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Cell and Developmental Biology
发表日期
2022-05-03
卷期
第 10 卷
页码
862675
DOI
10.3389/fcell.2022.862675
期刊等级
3区
成果收录
SCIE
资助标注
National Key R&D Program of China [2020YFC2005000]; National Natural Science Foundation of China [82070707, 91949114]; project of Innovation team of chronic kidney disease with integrated traditional Chinese and Western Medicine [2019KCXTD014]; Frontier Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110105004]; Outstanding Scholar Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110102004]; Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University [2019J013, 2021J001]; Presidential Foundation of Nanfang Hospital [2019Z006]; Guangdong Provincial Clinical Research Center for Kidney Disease [2020B1111170013]; China Postdoctoral Science Foundation [2020M672740]; Guangzhou Science and Technology project [2020YFC2005000]; Guangzhou Health science and Technology project [202102021296]; National Key R&D Program of China; National Natural Science Foundation of China [2020YFC2005000]; project of Innovation team of chronic kidney disease with integrated traditional Chinese and Western Medicine [82070707, 91949114]; Frontier Research Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2019KCXTD014]; Outstanding Scholar Program of Guangzhou Regenerative Medicine and Health Guangdong Laboratory [2018GZR110105004]; Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University [2018GZR110102004]; Presidential Foundation of Nanfang Hospital [2019J013, 2021J001]; Guangdong Provincial Clinical Research Center for Kidney Disease [2019Z006]; China Postdoctoral Science Foundation [2020B1111170013]; Guangzhou Science and Technology project [2020M672740]; Guangzhou Health science and Technology project [2020YFC2005000]; [20221A011115]

作者

  • M

    Meng, Ping (第一作者)

    southern med univ

  • H

    Huang, Jiewu

    southern med univ

查看全部 13 位作者收起作者
  • L

    Ling, Xian

    southern med univ

  • Z

    Zhou, Shan

    southern med univ

  • W

    Wei, Jingyan

    southern med univ

  • Z

    Zhu, Mingsheng

  • M

    Miao, Jinhua

    southern med univ

  • S

    Shen, Weiwei

    southern med univ

  • L

    Li, Jiemei

    southern med univ

  • Y

    Ye, Huiyun

    southern med univ

  • N

    Niu, Hongxin (通讯)

    southern med univ

  • Z

    Zhang, Yunfang (通讯)

    southern med univ

  • Z

    Zhou, Lili (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417